Pharmacokinetics/Pharmacodynamics of Albiglutide
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 283 participants.
Also called NCT01357889
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 283 participants
- Sponsor
- Registry
-
NCT01357889
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01357889. Randomized; double masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2012-10 (actual). Results posted on 2014-05-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmacokinetics/Pharmacodynamics of Albiglutide
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Biological)
- albiglutide (GSK716155)
- Intervention (Biological)
- albiglutide (GSK716155)
- Lead sponsor
- GlaxoSmithKline
Record details
- Record id
cardio:ct-nct01357889- Content hash
385e43a27653deff279b17f6f80b07f514f3294613b3ba00de61f14081b19997